Infliximab has been chosen because of its effective role in treating autoimmune and inflammatory conditions and established safety […]
The drug is already on the market to treat chronic lymphocytic leukaemia (CLL)
Improvements in key asthma outcomes have stalled in the last decade
Updated Date: Mon, 08 Jun 2020 00:00:00 EDT
Updated Date: Mon, 08 Jun 2020 00:00:00 EDT
Updated Date: Mon, 08 Jun 2020 00:00:00 EDT
Updated Date: Mon, 08 Jun 2020 00:00:00 EDT
Updated Date: Mon, 08 Jun 2020 00:00:00 EDT
Gilead sees better days ahead for CAR-T therapy Yescarta with Amsterdam manufacturing hub online kblankenship Mon, 06/15/2020 – […]